Previous close | 1.0900 |
Open | 1.0500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 125.00 |
Expiry date | 2024-11-15 |
Day's range | 1.0500 - 1.0900 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.
Recently, Zacks.com users have been paying close attention to AbbVie (ABBV). This makes it worthwhile to examine what the stock has in store.